OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$6,000,000
-92.6%
50,0000.0%0.00%
-100.0%
Q4 2013$81,000,000
-55.0%
50,0000.0%0.00%
-75.0%
Q3 2013$180,000,00050,0000.00%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q2 2014.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders